Lymphoma, Large B-Cell, Diffuse: Clinical Trials

5 trials for Lymphoma, Large B-Cell, Diffuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Lymphoma, Large B-Cell, Diffuse: new trials by email Literature Review of Lymphoma, Large B-Cell, Diffuse trials Research Report on Lymphoma, Large B-Cell, Diffuse

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
selinexor - Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 4UnknownChongqing University Cancer Hospital322023-02-282023-03-28
A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma
Decitabine - Diffuse Large B Cell Lymphoma
Phase 4UnknownMingzhi Zhang602018-06-012018-09-14
Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma
(R)-CHOP regimen, (R)-CVP regimen - Diffuse Large B Cell Lymphoma
Phase 4UnknownMingzhi Zhang202017-07-012018-05-01
Reduced Chemotherapy in Low Risk DLBCL
Rituximab, Cyclophosphamide, Epirubicin - Diffuse Large B-cell Lymphoma
Phase 4UnknownRuijin Hospital2902016-06-142022-12-05
Treatment of Diffuse Large B Cell Lymphoma
Yangzhengxiaoji capsule combined with CHOP regimen, CHOP regimen - Diffuse Large B Cell Lymphoma
Phase 4UnknownMingzhi Zhang1202012-09-012015-12-30

Broader conditions

Hemic and Lymphatic Diseases (5)  ·  Immune System Diseases (5)  ·  Immunoproliferative Disorders (5)  ·  Lymphatic Diseases (5)  ·  Lymphoma (5)  ·  Lymphoma, B-Cell (5)  ·  Lymphoma, Non-Hodgkin (5)  ·  Lymphoproliferative Disorders (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)

Interventions

Cyclophosphamide (1)  ·  Decitabine (1)  ·  Epirubicin (1)  ·  Prednisone (1)  ·  Rituximab (1)  ·  VAP-cyclo protocol (1)  ·  Vincristine (1)  ·  selinexor (1)

Sponsors

Mingzhi Zhang (3)  ·  Chongqing University Cancer Hospital (1)  ·  Ruijin Hospital (1)

Countries

China (5)

Top investigators

Mingzhi Zhang (1)  ·  Mingzhi Zhang, Dr (1)  ·  Weili Zhao, MD, PhD (1)

Results publications

PMID 16648042, PMID 19219604, PMID 20660832, PMID 23615461, PMID 23753028, PMID 25934708, PMID 29155058, PMID 29437609, PMID 29610030, PMID 29654631, PMID 30881137, PMID 32487143, PMID 32589977, PMID 33148342, PMID 33202794, PMID 33764240, PMID 34222013, PMID 37403255, PMID 7477169